Life Science REIT (LON:LABS) Trading Up 0.8% – Time to Buy?

Life Science REIT plc (LON:LABS)’s share price shot up 0.8% on Friday . The stock traded as high as GBX 38.50 ($0.49) and last traded at GBX 38.50 ($0.49). 480,578 shares traded hands during trading, a decline of 51% from the average session volume of 990,415 shares. The stock had previously closed at GBX 38.20 ($0.48).

Wall Street Analysts Forecast Growth

LABS has been the topic of a number of recent analyst reports. Jefferies Financial Group cut their target price on shares of Life Science REIT from GBX 45 ($0.57) to GBX 36 ($0.45) and set a “hold” rating on the stock in a research note on Friday, August 30th. Shore Capital reaffirmed a “buy” rating on shares of Life Science REIT in a report on Thursday, September 26th. Finally, Berenberg Bank reiterated a “buy” rating and issued a GBX 57 ($0.72) price target on shares of Life Science REIT in a report on Thursday, October 3rd.

Life Science REIT Price Performance

The company has a fifty day moving average price of GBX 39.82 and a two-hundred day moving average price of GBX 36.12. The firm has a market cap of £134.75 million, a price-to-earnings ratio of -641.67 and a beta of 0.08.

Life Science REIT Dividend Announcement

The business also recently declared a dividend, which was paid on Thursday, October 31st. Investors of record on Thursday, October 3rd were paid a GBX 1 ($0.01) dividend. The ex-dividend date of this dividend was Thursday, October 3rd. This represents a yield of 3.11%. Life Science REIT’s dividend payout ratio is currently -3,333.33%.

Life Science REIT Company Profile

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.